Detection of migration of locally implanted AC133+ stem cells by cellular magnetic resonance imaging with histological findings.
This study investigated the factors responsible for migration and homing of magnetically labeled AC133(+) cells at the sites of active angiogenesis in tumor. AC133(+) cells labeled with ferumoxide-protamine sulfate were mixed with either rat glioma or human melanoma cells and implanted in flank of nude mice. An MRI of the tumors including surrounding tissues was performed. Tumor sections were stained for Prussian blue (PB), platelet-derived growth factor (PDGF), hypoxia-inducible factor-1alpha (HIF-1alpha), stromal cell derived factor-1 (SDF-1), matrix metalloproteinase-2 (MMP-2), vascular endothelial growth factor (VEGF), and endothelial markers. Fresh snap-frozen strips from the central and peripheral parts of the tumor were collected for Western blotting. MRIs demonstrated hypointense regions at the periphery of the tumors where the PB(+)/AC133(+) cells were positive for endothelial cells markers. At the sites of PB(+)/AC133(+) cells, both HIF-1alpha and SDF-1 were strongly positive and PDGF and MMP-2 showed generalized expression in the tumor and surrounding tissues. There was no significant association of PB(+)/AC133(+) cell localization and VEGF expression in tumor cells. Western blot demonstrated strong expression of the SDF-1, MMP-2, and PDGF at the peripheral parts of the tumors. HIF-1alpha was expressed at both the periphery and central parts of the tumor. This work demonstrates that magnetically labeled cells can be used as probes for MRI and histological identification of administered cells.
Arbab
Ali S
AS
Department of Radiology, Henry Ford Health System, 1 Ford Pl., 2F, Box 82, Detroit, MI 48202, USA. saali@rad.hfh.edu
Janic
Branislava
B
Knight
Robert A
RA
Anderson
Stasia A
SA
Pawelczyk
Edyta
E
Rad
Ali M
AM
Read
Elizabeth J
EJ
Pandit
Sunil D
SD
Frank
Joseph A
JA
D000071916:AC133 Antigen; D000818:Animals; D015703:Antigens, CD / Q000378:metabolism; D015687:Cell Hypoxia / Q000502:physiology; D045744:Cell Line, Tumor; D002465:Cell Movement; D054377:Chemokine CXCL12 / Q000096:biosynthesis; D003911:Dextrans; D005260:Female; D052203:Ferrosoferric Oxide; D005910:Glioma / Q000473:pathology; D006023:Glycoproteins / Q000378:metabolism; D019650:Hematopoietic Stem Cell Mobilization; D006801:Humans; D051795:Hypoxia-Inducible Factor 1, alpha Subunit / Q000096:biosynthesis; D007501:Iron; D008279:Magnetic Resonance Imaging / Q000379:methods; D058185:Magnetite Nanoparticles; D020778:Matrix Metalloproteinase 2 / Q000096:biosynthesis; D018328:Melanoma, Amelanotic / Q000473:pathology; D045164:Mesenchymal Stem Cell Transplantation; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D009389:Neovascularization, Pathologic / Q000473:pathology*; D010087:Oxides; D010455:Peptides / Q000378:metabolism; D010982:Platelet-Derived Growth Factor / Q000096:biosynthesis; D011479:Protamines; D051381:Rats; D042461:Vascular Endothelial Growth Factor A / Q000096:biosynthesis
D000071916:AC133 Antigen; D015703:Antigens, CD; D054377:Chemokine CXCL12; C515256:Cxcl12 protein, mouse; D003911:Dextrans; D006023:Glycoproteins; C497443:Hif1a protein, mouse; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D058185:Magnetite Nanoparticles; D010087:Oxides; C000606023:PROM1 protein, human; D010455:Peptides; D010982:Platelet-Derived Growth Factor; C000606024:Prom1 protein, mouse; D011479:Protamines; D042461:Vascular Endothelial Growth Factor A; D007501:Iron; D020778:Matrix Metalloproteinase 2; C065507:ferumoxides; D052203:Ferrosoferric Oxide